|
This page and related links last reviewed on February 7, 2011
Background: The emergence of new medical technologies
both within and external to pathology and the laboratory is clearly accelerating—some
will be adopted, others will be quickly replaced by a more functional
or advanced innovation. The impact of these changes on pathologists and
the College of American Pathologists is not clear. However, it is evident
that some technologies have the potential to cause disruption of current
pathology practice while others provide a new or expanded pathway for
pathologists to bring incremental value to their clinical colleagues and
improve patient care. The College is challenged with the task of keeping
an eye on these developments, determining which technologies on which
to focus, and deciding how it can best support the specialty in preparing
for and integrating new technologies.
More about the Technology Assessment Committee
| Charge: |
- To evaluate emerging technologies (drug, device, test or process) and trends in the clinical laboratory setting that impact the practice of pathology
|
| |
- To educate members of technologies that are “new to the world” or those that are evolving technologies
|
| |
- To provide expertise and education to other programs and members of the CAP
|
| |
- To maintain liaisons with other relevant external organizations
|
|
|
|
Related Links
